Zhejiang XinNong Chemical Co.,Ltd. (SHE:002942)
China · Delayed Price · Currency is CNY 18.54
+0.57 (3.17%)
Sep 7, 2026, 1:25 PM CST
Zhejiang XinNong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,135 | 1,053 | 931.18 | 798.53 | 1,213 | 1,119 |
Other Revenue | 15.39 | 55.68 | 31.09 | 22.5 | 35.55 | 43.17 |
| 1,150 | 1,108 | 962.27 | 821.03 | 1,248 | 1,163 | |
Revenue Growth | 13.37% | 15.17% | 17.20% | -34.22% | 7.36% | -2.61% |
Cost of Revenue | 792.27 | 768.68 | 702.45 | 652.01 | 933.7 | 807.36 |
Gross Profit | 357.91 | 339.54 | 259.81 | 169.03 | 314.47 | 355.21 |
Selling, General & Admin | 165.09 | 164.36 | 147.13 | 153.12 | 148.65 | 140.3 |
Research & Development | 60.43 | 60.03 | 56.82 | 58.33 | 70.24 | 75.72 |
Other Operating Expenses | 5.96 | 2.86 | 1.21 | 7.59 | 6.68 | 5.71 |
Operating Expenses | 230.57 | 229.88 | 207.12 | 216.38 | 227.02 | 221.69 |
Operating Income | 127.33 | 109.67 | 52.69 | -47.36 | 87.45 | 133.52 |
Interest Expense | -0.53 | -1.47 | -0.16 | -0.1 | -0.14 | -2.15 |
Interest & Investment Income | 19.03 | 13.79 | 14.69 | 8.46 | 5.76 | 21.61 |
Currency Exchange Gain (Loss) | 4.31 | 4.11 | 2.79 | 2.38 | 11.86 | -2.3 |
Other Non Operating Income (Expenses) | -14.38 | -8.31 | -2.3 | -0.59 | 0.71 | -0.84 |
EBT Excluding Unusual Items | 135.76 | 117.79 | 67.7 | -37.2 | 105.65 | 149.84 |
Gain (Loss) on Sale of Investments | 0.26 | 6.1 | 2.47 | 4.49 | -3.93 | 1.35 |
Gain (Loss) on Sale of Assets | -0.59 | -0.72 | -0.74 | 0.34 | 0.11 | -0.2 |
Asset Writedown | -23.66 | -23.59 | -15.27 | -7.1 | -0.18 | -1.05 |
Legal Settlements | - | - | -0.56 | - | - | - |
Other Unusual Items | 5.31 | 6.56 | 8.9 | 9.11 | 8.38 | 3.23 |
Pretax Income | 117.08 | 106.13 | 62.5 | -30.36 | 110.04 | 153.16 |
Income Tax Expense | 10.07 | 10.73 | 4.77 | -4.98 | 8.64 | 15.29 |
Net Income | 107.01 | 95.41 | 57.73 | -25.37 | 101.4 | 137.87 |
Net Income to Common | 107.01 | 95.41 | 57.73 | -25.37 | 101.4 | 137.87 |
Net Income Growth | 33.56% | 65.27% | - | - | -26.46% | -21.32% |
Shares Outstanding (Basic) | 153 | 154 | 152 | 149 | 154 | 157 |
Shares Outstanding (Diluted) | 153 | 154 | 152 | 149 | 154 | 157 |
Shares Change | 0.46% | 1.29% | 1.78% | -2.84% | -1.94% | 0.13% |
EPS (Basic) | 0.70 | 0.62 | 0.38 | -0.17 | 0.66 | 0.88 |
EPS (Diluted) | 0.70 | 0.62 | 0.38 | -0.17 | 0.66 | 0.88 |
EPS Growth | 32.96% | 63.16% | - | - | -25.00% | -21.43% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 119.51 | 82.5 | 108.91 | 19.07 | 42.67 | 84.46 |
Free Cash Flow Per Share | 0.78 | 0.54 | 0.72 | 0.13 | 0.28 | 0.54 |
Dividend Per Share | 0.400 | 0.400 | 0.300 | 0.200 | 0.250 | 0.500 |
Dividend Growth | 33.33% | 33.33% | 50.00% | -20.00% | -50.00% | 116.64% |
Gross Margin | 31.12% | 30.64% | 27.00% | 20.59% | 25.20% | 30.55% |
Operating Margin | 11.07% | 9.90% | 5.47% | -5.77% | 7.01% | 11.48% |
Profit Margin | 9.30% | 8.61% | 6.00% | -3.09% | 8.12% | 11.86% |
Free Cash Flow Margin | 10.39% | 7.45% | 11.32% | 2.32% | 3.42% | 7.27% |
EBITDA | 176.88 | 157.9 | 104.7 | 2.03 | 133.07 | 174.53 |
EBITDA Margin | 15.38% | 14.25% | 10.88% | 0.25% | 10.66% | 15.01% |
D&A For EBITDA | 49.54 | 48.23 | 52.01 | 49.39 | 45.62 | 41.01 |
EBIT | 127.33 | 109.67 | 52.69 | -47.36 | 87.45 | 133.52 |
EBIT Margin | 11.07% | 9.90% | 5.47% | -5.77% | 7.01% | 11.48% |
Effective Tax Rate | 8.60% | 10.11% | 7.63% | - | 7.85% | 9.98% |
Revenue as Reported | 517.02 | 1,108 | 962.27 | 821.03 | 1,248 | 1,163 |